Dimerix Receives AU$3.2 Million Upfront Payment From FUSO Pharmaceutical Under DMX-200 License Deal

MT NewswiresMar 3 22:32 ET

Dimerix Ltd: Half-Year Financial Report & Appendix 4D - 31 December 2024

ASXFeb 24 17:07 ET · Announcements

Lowering Dimerix's Phase 3 Trial Hurdles to Boost Kidney Failure Treatment Drug Appeal, Euroz Hartleys Says.

MT NewswiresFeb 10 18:40 ET

Dimerix Exclusive Japan Licensing Deal 'Positive Suprise,' Euroz Hartleys Says

MT NewswiresJan 9 00:41 ET

Dimerix Inks Exclusive License Deal With Fuso Pharmaceutical for Kidney Disease Drug Candidate; Shares Soar 23%

MT NewswiresJan 6 20:24 ET

ASX Biggest Gainers

MT NewswiresJan 6 19:38 ET